These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3004953)

  • 1. Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized in E. coli.
    Jacob CO; Leitner M; Zamir A; Salomon D; Arnon R
    EMBO J; 1985 Dec; 4(12):3339-43. PubMed ID: 3004953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides.
    Jacob CO; Arnon R; Finkelstein RA
    Infect Immun; 1986 May; 52(2):562-7. PubMed ID: 3009330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of heat-labile toxin of E. coli by antibodies to synthetic peptides derived from the B subunit of cholera toxin.
    Jacob CO; Pines M; Arnon R
    EMBO J; 1984 Dec; 3(12):2889-93. PubMed ID: 6098453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
    Zhang C; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization with a synthetic peptide of cholera toxin B subunit. Obtention of neutralizing antibodies.
    Guyon-Gruaz A; Delmas A; Pedoussaut S; Halimi H; Milhaud G; Raulais D; Rivaille P
    Eur J Biochem; 1986 Sep; 159(3):525-8. PubMed ID: 3758076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    Infect Immun; 1984 Mar; 43(3):811-6. PubMed ID: 6365784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic and antigenic characteristics of Salmonella heat-labile enterotoxin.
    Kaura YK; Sharma VK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):386-404. PubMed ID: 3136609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.
    Tamura S; Yamanaka A; Shimohara M; Tomita T; Komase K; Tsuda Y; Suzuki Y; Nagamine T; Kawahara K; Danbara H
    Vaccine; 1994 Apr; 12(5):419-26. PubMed ID: 8023550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
    Bowman CC; Clements JD
    Infect Immun; 2001 Mar; 69(3):1528-35. PubMed ID: 11179323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology.
    Levine MM; Young CR; Black RE; Takeda Y; Finkelstein RA
    J Clin Microbiol; 1985 Feb; 21(2):174-9. PubMed ID: 3882744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins.
    Rappuoli R; Pizza M; Douce G; Dougan G
    Immunol Today; 1999 Nov; 20(11):493-500. PubMed ID: 10529776
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of monoclonal antibodies to heat-labile enterotoxin encoded by a plasmid from a clinical isolate of Escherichia coli.
    Belisle BW; Twiddy EM; Holmes RK
    Infect Immun; 1984 Mar; 43(3):1027-32. PubMed ID: 6365779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptides with antigenic specificity for bacterial toxins.
    Sela M; Arnon R; Jacob CO
    Ciba Found Symp; 1986; 119():184-99. PubMed ID: 2426052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.
    Gilligan PH; Brown JC; Robertson DC
    Infect Immun; 1983 Nov; 42(2):683-91. PubMed ID: 6196292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.
    Klipstein FA; Engert RF
    Infect Immun; 1977 Oct; 18(1):110-7. PubMed ID: 332637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin.
    Lindholm L; Holmgren J; Wikström M; Karlsson U; Andersson K; Lycke N
    Infect Immun; 1983 May; 40(2):570-6. PubMed ID: 6840852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a monoclonal antibody that recognizes the amino-terminal decapeptide of the B-subunit of Escherichia coli heat-labile enterotoxin. A new probe for studying toxin assembly intermediates.
    Amin T; Larkins A; James RF; Hirst TR
    J Biol Chem; 1995 Aug; 270(34):20143-50. PubMed ID: 7544352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine.
    Lebens M; Shahabi V; Bäckström M; Houze T; Lindblad N; Holmgren J
    Infect Immun; 1996 Jun; 64(6):2144-50. PubMed ID: 8675319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulatory role of H-2 and intra-H-2 alleles on antibody responses to recombinant preparations of B-subunits of Escherichia coli heat-labile enterotoxin (rEtxB) and cholera toxin (rCtxB).
    Nashar TO; Hirst TR
    Vaccine; 1995 Jun; 13(9):803-10. PubMed ID: 7483801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.